South Korea bans remote prescribing of weight loss drugs like Wegovy, aiming to curb abuse.

South Korea's health ministry plans to ban remote prescribing of weight loss drugs like Wegovy, effective Monday with a two-week grace period. The move aims to curb abuse and illegal sales, especially of the popular Wegovy. The government will set guidelines for telemedicine consultations on these medications by mid-2025. This ban follows a temporary allowance for telemedicine due to a trainee doctor strike.

November 29, 2024
3 Articles

Further Reading